AGIOS PHARMACEUTICALS, INC.·4

Jun 23, 4:11 PM ET

MARAGANORE JOHN 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 23, 2022

Insider Transaction Report

Form 4
Period: 2022-06-21
Transactions
  • Award

    Restricted stock unit

    2022-06-21+4,9754,975 total
    Common stock (4,975 underlying)
  • Award

    Stock options (right to buy)

    2022-06-21+29,30729,307 total
    Exercise: $18.09Exp: 2032-06-21Common stock (29,307 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
  • [F3]This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023.

Documents

1 file
  • 4
    wf-form4_165601503086291.xmlPrimary

    FORM 4